Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15-75
SponsorBeijing Tiantan Hospital

About this trial

This research employs AI to analyze facial expressions and speech patterns, aiming to develop new digital tools for diagnosing and differentiating Parkinson's disease and similar disorders.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Inclusion Criteria for Parkinson's Disease (PD) Group: (1) Diagnostic Criteria: Meet the diagnostic criteria for Parkinson's disease established by the Movement Disorder Society (MDS) in 2015. (2) Age Range: 18-75 years old. (3) Disease Severity: Early-stage PD: Hoehn-Yahr score ≤ 2.5 points. Mid-to-late-stage PD: Hoehn-Yahr score 2.5-5 points. (4) Consent for Data Collection: Willing to undergo facial expression video and speech audio recording. (5) Informed Consent: Signed informed consent form.

Inclusion Criteria for Parkinson's Plus Syndromes (MSA-P, PSP) Group: (1) Age Range: 18-75 years old. (2) Diagnostic Criteria: MSA patients must meet the diagnostic criteria established by the [Chinese Expert Consensus on the Diagnosis of Multiple System Atrophy, 2017]. PSP patients must meet the diagnostic criteria established by the [Chinese Clinical Diagnostic Criteria for Progressive Supranuclear Palsy, 2016 Edition]. (3) Consent for Data Collection: Willing to undergo facial expression video and speech audio recording. (4) Informed Consent: Signed informed consent form.

Disqualifiers

History of cerebrovascular disease, head trauma, hydrocephalus, brain tumors, or intracranial surgery.

Presence of metal implants, cardiac pacemakers, or other metallic foreign bodies (applies to PD patients).

Severe dyskinesia in PD patients that would compromise cooperation with video/audio recording.

Mini-Mental State Examination (MMSE) score ≤ 24 points.

Trial population

In this study, participants were recruited from a single center in China. They were enrolled through outpatient assessment and screening.

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

  • video recording

    Other intervention

    The patient's facial expressions and speech characteristics were recorded via video for assessment purposes.

Treatment groups

720 Participants
are divided into 4 treatment groups
Group A: Parkinson's disease (PD) group1 intervention
Group B: Multiple System Atrophy (MSA) Group1 intervention
Group C: Progressive Supranuclear Palsy (PSP) Group1 intervention
Group D: Healthy Control Group1 intervention

Trial outcomes

Primary outcomes

1

Diagnostic Accuracy of the AI Model in Assessing [ Disease/Condition ] Severity

The effectiveness of the model was demonstrated through a comparison between model-predicted scores and human expert ratings.

Time frame
Baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.